SkyePharma Plc said that it has applied to have its asthma treatment, Flutiform, approved for marketing in Europe, while preparations are underway to test the drug in Phase 3 trials in Japan. The UK company gave the product update on 12 May 2010.
SkyePharma Plc said that it has applied to have its asthma treatment, Flutiform, approved for marketing in Europe, while preparations are underway to test the drug in Phase 3 trials in Japan. The UK company gave the product update on 12 May 2010.